Deere & Company is doubling down on American manufacturing with a new excavator plant and parts center, part of a broader $20 billion commitment. While the move strengthens its long-term industrial narrative, near-term challenges from leadership changes to cyclical market pressures remain in focus.
A wave of updated price targets from Wall Street analysts is prompting investors to reassess Diana Shipping Inc. The shifting forecasts reflect changing views on dry bulk shipping fundamentals and the company's strategic position, moving the stock's story beyond recent quarters.
As Amazon navigates AI investments and cost-cutting, financial analysts are split on its 2026 stock trajectory. While some see stretched valuations, others point to AWS and advertising as engines for further growth.
Following a robust Q4 earnings beat, IBM's strategic focus on hybrid cloud, AI, and quantum computing earns a price target upgrade from Bank of America, with analysts citing improved growth and free cash flow trajectory.
Barrick Mining Corporation's stock fell nearly 10% Friday, mirroring a sharp drop in gold prices after President Trump's nomination of a mainstream candidate to lead the Federal Reserve calmed market anxieties about runaway inflation.
A growing financial strategy known as 'soft switching'—opening new bank accounts without closing old ones—is gaining traction. Experts say it can unlock higher yields, better features, and greater flexibility, but requires careful management to avoid pitfalls.
As gold prices soar past $5,400 an ounce before a sharp pullback, a global rush is underway. From Parisian boutiques to Main Street dealers, consumers are capitalizing on heirlooms or diving into the market, driven by geopolitical tensions and economic uncertainty.
Millions of Social Security beneficiaries will see their February payments arrive on schedule, with amounts reflecting this year's cost-of-living adjustment. Here is the complete calendar and key details.
Apple's Q1 earnings showcased blockbuster iPhone revenue of $85.3 billion, yet investor caution prevails amid persistent supply chain constraints and mounting cost pressures that threaten near-term profitability.
Medical Properties Trust (NYSE: MPW), a major healthcare real estate investment trust, is relocating its corporate headquarters to Birmingham, Alabama. The move is seen as a strategic effort to streamline operations and deepen ties with its primary U.S. hospital network, lenders, and investors, amid an evolving landscape for hospital ownership and healthcare infrastructure.
The historic Farmers' Almanac, famed for its secret weather formula, has been acquired by digital media company Unofficial Networks. The move saves the publication from shuttering, relocates its operations from Maine to New York, and promises a digital-first revival alongside a planned return to print.
Financial planners are urging a shift in mindset: the date on your retirement party invitation matters less than the balance in your investment portfolio. We break down the calculations that show whether you're truly ready to leave the workforce.
A sharp, unexpected jump in wholesale prices complicates the White House's economic narrative and its pressure campaign on the Federal Reserve for rate cuts.
Regeneron Pharmaceuticals is positioning its experimental obesity drug, olatorepatide, as a potential game-changer by combining significant weight loss with a dramatic reduction in 'bad' cholesterol. The company believes this dual benefit could carve out a unique niche in the competitive $150 billion market, currently led by Novo Nordisk and Eli Lilly.
Amidst a choppy market, value investors are hunting for bargains. We spotlight three companies—Dingdong, Origin Bancorp, and ATRenew—whose current share prices appear significantly disconnected from their estimated intrinsic value, presenting potential opportunities for the discerning investor.
Facing rising postpaid churn and prepaid losses, AT&T is aggressively pushing bundled phone and internet packages as its core retention strategy, betting that convergence can stem the tide of subscribers fleeing to rivals and cable companies.
Shares of diabetes care innovator Insulet have tumbled nearly 10% year-to-date, sparking a fierce debate among investors. While a key valuation model suggests the stock is deeply undervalued, its sky-high P/E ratio tells a conflicting story. We examine the numbers and what they mean for the future of the Omnipod maker.
Bank of America extends its partnership with Volvo Car Financial Services through 2030, solidifying its position in automotive lending. Concurrently, the bank joins JPMorgan Chase in matching contributions to the new federal 'Trump Accounts' child savings program, while advancing a dual-track expansion in digital services and physical branches.
Regeneron Pharmaceuticals reported a steady finish to 2025, driven by growth in key drugs Dupixent and EYLEA HD. While navigating competitive pressures on its legacy blockbuster, the biotech giant outlined an ambitious 2026 strategy focused on regulatory milestones and a broad clinical pipeline.
Microsoft shares suffered their steepest single-day drop in over three years after Azure cloud growth narrowly missed estimates, revealing the complex trade-offs between fueling internal AI projects and meeting soaring external demand.
